Skip to main content

EBV Related PTCL clinical trials at UCSF

1 research study open to eligible people

EBV related PTCL is a lymphoma, a cancer of lymph nodes, caused by Epstein-Barr virus. UCSF is carrying out trials to see how well nanatinostat and valganciclovir work together to fight this cancer. These are phase 2 trials, where we check if the treatment works.

Showing trials for

Last updated: